Posts by Daniel Singer, MD
-
Primary Care Screening for Atrial Fibrillation in Older Adults Feasible But Inefficient
Massachusetts General Hospital researchers and colleagues found routine screening for atrial fibrillation (AF) using hand-held single-lead electrocardiography was accepted by 91% of older adults at primary care clinics, but screening did not significantly increase new AF diagnoses compared with usual care.
-
New Trial to Determine Whether Atrial Fibrillation Screening Reduces Stroke Risk
The GUARD-AF trial is a randomized screening trial that seeks to clarify whether atrial fibrillation screening in older individuals leads to a reduction in stroke.
Biography
Daniel E. Singer, MD, is Professor of Medicine at Harvard Medical School, Professor in the Department of Epidemiology at the Harvard School of Public Health, and Associate Chief for Research in the Division of General Internal Medicine at Massachusetts General Hospital. Dr. Singer has applied epidemiologic methods, including both observational studies and randomized trials, to common medical conditions. He is most widely recognized for his contributions to stroke prevention in atrial fibrillation. He has, as well, worked with Dr. Nancy Rigotti for more than 25 years on studies of smoking cessation. Dr. Singer’s research work has been recognized by several awards, including the Society of General Internal Medicine’s highest research award, the John Eisenberg Award, and his training of mentees by Harvard Medical School’s William Silen Award for lifetime achievements in mentoring.
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.